HBM Healthcare Investments
HBM Healthcare Investments

HBM Healthcare Investments

2001Investment Firm3 portfolio$3.0B AUMSwitzerland

About

Listed on SIX Swiss Exchange (HBMN), HBM Healthcare Investments is a Swiss investment company holding a well-balanced globally diversified portfolio of investments in private and public healthcare companies.

Key facts

At-a-glance profile data

Website
hbmpartners.com
Type
Investment Firm
Headquarters
Switzerland
Funds raised
$3.0B
Portfolio companies
3
Stages
Series A
Series B
Series C
Cheque size
$56M to $333M
Sector focus
Healthcare
Drug Development
Genomics
Next Generation Sequencing
Biotech

Recent investments

Recent funding rounds HBM Healthcare Investments took part in
DateCompanyRoundAmount
16 Oct 2025TubulisSeries C$333M
6 May 2024KariusSeries C$100M
23 Aug 202380073Series D$75M
8 Jun 2023Upstream BioSeries B$200M
2 Jun 2022Upstream BioSeries A$200M
21 Sept 202080073Series C$57M
24 Feb 2020KariusSeries B$165M
Add first review

Frequently asked

What companies has HBM Healthcare Investments invested in?

HBM Healthcare Investments has invested in Tubulis, Karius, 80073, Upstream Bio, FORE Biotherapeutics.

AUM
$3.0B
PORTFOLIO
3